StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SBCW

SBC Medical Group Holdings Incorporated

SBCWW Nasdaq Services-Offices & Clinics of Doctors of Medicine EDGAR ↗
$0.22
-0.04 -15.38%

Key statistics

from XBRL data in SEC filings
Market cap
$22.6M
Revenue (TTM)
$169M
Net income (TTM)
$40.8M
EPS (TTM)
$0.40
P/E ratio
0.6
Dividend yield
Free cash flow
$23.3M
Cash
$167M
Total assets
$388M
Gross margin
70.8%
52-week range
$0.21 – $0.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jul 14, 2026 8-K Director or officer change May 20, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Entered a material agreement Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Mar 27, 2026 8-K Regulation FD disclosure; Other events Jan 5, 2026 8-K Regulation FD disclosure; Other events Dec 31, 2025 8-K Other events Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Regulation FD disclosure Jul 17, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K/A Fiscal year ended 2024-12-31 May 9, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Director or officer change Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Mar 28, 2025 8-K Regulation FD disclosure Feb 18, 2025 8-K Regulation FD disclosure Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure; Other events Sep 20, 2024 8-K Shareholder vote results; Regulation FD disclosure Aug 29, 2024 8-K Regulation FD disclosure Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 16, 2024 8-K Entered a material agreement Aug 12, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 8-K Delisting notice or listing-rule failure May 8, 2024 8-K Entered a material agreement Apr 23, 2024 8-K Delisting notice or listing-rule failure Apr 4, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024